Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors
Tel-Aviv Sourasky Medical Center
Tel-Aviv Sourasky Medical Center
A2 Biotherapeutics Inc.
University of Nebraska
Adela, Inc
Elephas
Harvard Medical School (HMS and HSDM)
Elephas
Centre Hospitalier Universitaire de Besancon
University Health Network, Toronto
Massive Bio, Inc.
University of Texas Southwestern Medical Center
Delfi Diagnostics Inc.
A2 Biotherapeutics Inc.
Institut Bergonié
Tempus AI
Arbeitsgemeinschaft medikamentoese Tumortherapie
Pfizer
University Health Network, Toronto
Taproot Health
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Sanguine Biosciences
Cambridge University Hospitals NHS Foundation Trust
Exact Sciences Corporation
Weprom
University of Dundee
SpeciCare
University Hospital, Tours
University of Zurich
CureOne
GlaxoSmithKline
Amgen
M.D. Anderson Cancer Center
National Cancer Institute (NCI)